Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

Wanwu Xinsheng upgrades to $100m series E-plus

Formerly known as Aihuishou, the electronics recycler has attracted more than $100m in series E-plus funding co-led by existing shareholder JD.com.


Sep 23, 2020

Nucarf embraces $100m across two rounds

Nucarf has procured approximately $100m in combined series A and A-plus funding, with the former round featuring Xiamen C&D.

Sep 23, 2020

Swire Pacific helps plant $70m in Green Monday

Green Monday is working on a plant-based alternative to pork and has raised the money from investors including Swire Pacific and returning backer Lee Kum Kee Health Products.

Sep 23, 2020

Pureos Bioventures closes $170m fund

Pureos Bioventures has backed five spinouts so far from its multi-corporate-backed, biotech-focused fund.

Sep 23, 2020

Pureos Bioventures closes $170m fund

Pureos Bioventures has backed five spinouts so far from its inaugural biotech-focused fund, which has reached its final close.

Sep 23, 2020

Polyneuron binds in extra series A cash

HBM Healthcare chipped in additional funding to bring University of Basel spinout Polyneuron's series A round to $39.7m.

Sep 23, 2020

Beyond Limits lines up $133m series C

Group 42 and BP Ventures have co-led a series C round for Caltech and Nasa spinout Beyond Limits, with $113m already closed.

Sep 23, 2020

Virogin Biotech transmits $62m series C

Backed by Shanghai Fudan University previously, Virogin Biotech will invest the series C proceeds in its clinical drug programmes and securing industry partnerships.

Sep 23, 2020

Virogin Biotech transmits $62m series C

Backed by Sinopharm Capital previously, Virogin Biotech will invest the series C proceeds in its clinical drug programmes and securing industry partnerships.

Sep 23, 2020

Outschool passes $45m series B test

Sesame Workshop's online education portfolio company has raised fresh funding to seize on higher demand during the coronavirus pandemic.

Sep 23, 2020

Carlyle Group to screen TriNetX for acquisition

TriNetX had raised $102m in funding from investors including Merck & Co, Mitsui and Itochu before agreeing to a purchase by Carlyle.

Sep 23, 2020

Corporates meet Novellus in $57m series C

Precision cancer drug developer Novellus boosted its funding total to $75.5m with a round featuring SR One and Novartis Venture Fund.

Sep 23, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here